Post‐prandial lipoprotein metabolism in nephrotic syndrome
- 1 December 1992
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 22 (12) , 813-820
- https://doi.org/10.1111/j.1365-2362.1992.tb01451.x
Abstract
Post‐prandial lipaemia was investigated in a group of nine subjects with nephrotic syndrome by following the concentrations of triglyceride and retinyl palmitate in the d< 1.006 g ml‐1 fraction of plasma after a standard oral fat load containing vitamin A. Lipoprotein lipase and hepatic triglyceride lipase activities were measured in post‐heparin plasma. Subjects with other renal disease but insignificant protein‐uria acted as controls. The time course of the lipaemic response was similar in both groups although individual patients demonstrated a prolonged lipaemia. Overall, there were no significant differences in the rise in triglyceride at 6 h (nephrotic—median 2.53 mmol 1‐1; range 0.87–4.76 vs. control 1.88; 0.38–4.12, p= 0.34), the peak concentration of retinyl palmitate (nephrotic 0.87 mg dl‐1; 0.27–2.16 vs. control 0.65; 0.24–1.89, P= 0.97) or the areas under the curve from 0.24 h for triglyceride (nephrotic 10.5 mmol. h l‐1; 2.9–43.6 vs. control 9.7; 4.3–27.0, P=l.0) or retinyl palmitate (5.5 mg.h dl‐1; 1.0–23.4 vs. 4.3; 1.5–12.4, P= 0.7). At baseline, the particles in the d < 1.006 g ml‐1 fraction of plasma from nephrotic subjects had a higher free cholesterol: phospholipid ratio but this difference was no longer apparent 6 h after the test meal. There were no differences in total heparin‐releasable lipase, lipoprotein lipase or hepatic triglyceride lipase activities between the two groups. These data suggest that impaired clearance of chylomicrons is not a major contributor to nephrotic hyperlipidae‐mia in man.Keywords
This publication has 43 references indexed in Scilit:
- Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic originBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Analysis of serial measurements in medical research.BMJ, 1990
- Chylomicron synthesis in experimental nephrotic syndromeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Retinyl ester retention in chronic renal failure Further evidence for a defect in chylomicron remnant metabolismAtherosclerosis, 1985
- Plasma Post-Heparin Lipolytic Activity in Rats with Nephrotic SyndromeHormone and Metabolic Research, 1983
- Atherogenesis: a postprandial phenomenon.Circulation, 1979
- Human lipoprotein lipase inhibition of activity by cholesterolBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970
- SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSISJournal of Clinical Investigation, 1960
- STUDIES ON THE METABOLISM OF PLASMA PROTEINS IN THE NEPHROTIC SYNDROME. II. THE LIPOPROTEINS12Journal of Clinical Investigation, 1958